Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatrics. 2007 Oct;120(4):834-41.

New approaches to progeria.

Author information

1
Dana-Farber Cancer Institute, Department of Pediatric Oncology, 44 Binney St, Boston, MA 02115, USA. mark_kieran@dfci.harvard.edu

Erratum in

  • Pediatrics. 2007 Dec;120(6):1405.

Abstract

Progeria (Hutchinson-Gilford progeria syndrome) is a rare genetic disorder that offers considerable insight into the biology of premature aging. This review summarizes the clinical characteristics of this disease and the underlying mutation in the lamin A (LMNA) gene that results in this phenotype. Modifications in the processing of prelamin A through alterations in farnesylation are detailed, because this pathway offers a possible drug target. Finally, discussion of an ongoing clinical trial for these children, including possible parameters for evaluation, are discussed. In the span of less than a decade, this disease has progressed from an interesting phenotype to one in which the gene defect has been identified, animal models have been created and tested with drugs that target the primary disease pathway, and significant clinical baseline data for the support of a clinical trial have been obtained.

PMID:
17908771
DOI:
10.1542/peds.2007-1356
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center